BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 22274000)

  • 1. Low BDNF is associated with cognitive impairment in chronic patients with schizophrenia.
    Zhang XY; Liang J; Chen DC; Xiu MH; Yang FD; Kosten TA; Kosten TR
    Psychopharmacology (Berl); 2012 Jul; 222(2):277-84. PubMed ID: 22274000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender difference in association of cognition with BDNF in chronic schizophrenia.
    Zhang XY; Chen DC; Tan YL; Tan SP; Wang ZR; Yang FD; Xiu MH; Hui L; Lv MH; Zunta-Soares GB; Soares JC
    Psychoneuroendocrinology; 2014 Oct; 48():136-46. PubMed ID: 24999831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive and serum BDNF correlates of BDNF Val66Met gene polymorphism in patients with schizophrenia and normal controls.
    Zhang XY; Chen DC; Xiu MH; Haile CN; Luo X; Xu K; Zhang HP; Zuo L; Zhang Z; Zhang X; Kosten TA; Kosten TR
    Hum Genet; 2012 Jul; 131(7):1187-95. PubMed ID: 22362486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered BDNF is correlated to cognition impairment in schizophrenia patients with tardive dyskinesia.
    Wu JQ; Chen DC; Tan YL; Tan SP; Hui L; Lv MH; Soares JC; Zhang XY
    Psychopharmacology (Berl); 2015 Jan; 232(1):223-32. PubMed ID: 24994553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive impairments and low BDNF serum levels in first-episode drug-naive patients with schizophrenia.
    Man L; Lv X; Du XD; Yin G; Zhu X; Zhang Y; Soares JC; Yang XN; Chen X; Zhang XY
    Psychiatry Res; 2018 May; 263():1-6. PubMed ID: 29482040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma total antioxidant status and cognitive impairments in schizophrenia.
    Zhang XY; Chen DC; Xiu MH; Tang W; Zhang F; Liu L; Chen Y; Liu J; Yao JK; Kosten TA; Kosten TR
    Schizophr Res; 2012 Aug; 139(1-3):66-72. PubMed ID: 22555016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low BDNF is associated with cognitive deficits in patients with type 2 diabetes.
    Zhen YF; Zhang J; Liu XY; Fang H; Tian LB; Zhou DH; Kosten TR; Zhang XY
    Psychopharmacology (Berl); 2013 May; 227(1):93-100. PubMed ID: 23263460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain-derived neurotrophic factor as a biomarker for cognitive recovery in acute schizophrenia: 12-week results from a prospective longitudinal study.
    Zhang Y; Fang X; Fan W; Tang W; Cai J; Song L; Zhang C
    Psychopharmacology (Berl); 2018 Apr; 235(4):1191-1198. PubMed ID: 29392373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain-derived neurotrophic factor is associated with cognitive impairments in first-episode and chronic schizophrenia.
    Yang Y; Liu Y; Wang G; Hei G; Wang X; Li R; Li L; Wu R; Zhao J
    Psychiatry Res; 2019 Mar; 273():528-536. PubMed ID: 30710808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effects of BDNF Val66Met Gene Polymorphism on Serum BDNF and Cognitive Function in Methamphetamine-Dependent Patients and Normal Controls: A Case-Control Study.
    Su H; Tao J; Zhang J; Xie Y; Wang Y; Zhang Y; Han B; Lu Y; Sun H; Wei Y; Zou S; Wu W; Zhang J; Xu K; Zhang X; He J
    J Clin Psychopharmacol; 2015 Oct; 35(5):517-24. PubMed ID: 26280836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased BDNF may not be associated with cognitive impairment in heroin-dependent patients.
    Luan X; Tao J; Zhang J; Xie Y; Zhang X; Su H; He J
    Medicine (Baltimore); 2017 Apr; 96(15):e6582. PubMed ID: 28403087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low BDNF is associated with cognitive impairments in patients with Parkinson's disease.
    Wang Y; Liu H; Zhang BS; Soares JC; Zhang XY
    Parkinsonism Relat Disord; 2016 Aug; 29():66-71. PubMed ID: 27245919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thioredoxin, a novel oxidative stress marker and cognitive performance in chronic and medicated schizophrenia versus healthy controls.
    Zhang XY; Chen DC; Xiu MH; Yang FD; Tan YL; He S; Kosten TA; Kosten TR
    Schizophr Res; 2013 Feb; 143(2-3):301-6. PubMed ID: 23238053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BDNF serum levels and cognitive improvement in drug-naive first episode patients with schizophrenia: A prospective 12-week longitudinal study.
    Wu ZW; Shi H; Chen DC; Chen S; Xiu MH; Zhang XY
    Psychoneuroendocrinology; 2020 Dec; 122():104879. PubMed ID: 33049658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is serum brain-derived neurotrophic factor a biomarker for cognitive enhancement in schizophrenia?
    Vinogradov S; Fisher M; Holland C; Shelly W; Wolkowitz O; Mellon SH
    Biol Psychiatry; 2009 Sep; 66(6):549-53. PubMed ID: 19368899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations of serum brain-derived neurotrophic factor with cognitive impairments and negative symptoms in schizophrenia.
    Niitsu T; Shirayama Y; Matsuzawa D; Hasegawa T; Kanahara N; Hashimoto T; Shiraishi T; Shiina A; Fukami G; Fujisaki M; Watanabe H; Nakazato M; Asano M; Kimura S; Hashimoto K; Iyo M
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Dec; 35(8):1836-40. PubMed ID: 21930178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of peripheral levels of chemokines, BDNF and oxidative markers on cognition in individuals with schizophrenia.
    Asevedo E; Gadelha A; Noto C; Mansur RB; Zugman A; Belangero SI; Berberian AA; Scarpato BS; Leclerc E; Teixeira AL; Gama CS; Bressan RA; Brietzke E
    J Psychiatr Res; 2013 Oct; 47(10):1376-82. PubMed ID: 23806580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Burnout and cognitive impairment: Associated with serum BDNF in a Chinese Han population.
    He SC; Zhang YY; Zhan JY; Wang C; Du XD; Yin GZ; Cao B; Ning YP; Soares JC; Zhang XY
    Psychoneuroendocrinology; 2017 Mar; 77():236-243. PubMed ID: 28119229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers.
    Ho BC; Milev P; O'Leary DS; Librant A; Andreasen NC; Wassink TH
    Arch Gen Psychiatry; 2006 Jul; 63(7):731-40. PubMed ID: 16818862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary Associations Between Brain-Derived Neurotrophic Factor, Memory Impairment, Functional Cognition, and Depressive Symptoms Following Severe TBI.
    Failla MD; Juengst SB; Arenth PM; Wagner AK
    Neurorehabil Neural Repair; 2016 Jun; 30(5):419-30. PubMed ID: 26276123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.